The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Artificial Intelligence In Life Sciences Market Over The 2026–2030 Period?
The artificial intelligence in life sciences market has seen substantial growth in recent years. It is anticipated to expand from $3.59 billion in 2025 to $4.44 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. The historical surge can be attributed to the increasing complexity of biological datasets, the expansion of genomics research, the rising adoption of digital lab technologies, the early integration of ai in biotechnology research, and the growing demand for faster research cycles.
The artificial intelligence in life sciences market is projected to experience rapid expansion over the upcoming years. This market is predicted to reach $10.43 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.8%. Factors driving this growth during the forecast period include greater investments in personalized medicine, the expanding use of AI-enabled laboratory automation, the widening availability of cloud-based life science platforms, increased partnerships between technology and life science companies, and improved regulatory approval of AI-powered insights. Key trends anticipated for this period encompass the broader integration of AI across various life science workflows, the increasing uptake of AI-driven data analytics platforms, the enhanced application of automation in laboratory processes, the extension of AI-supported precision medicine uses, and a stronger emphasis on speeding up research findings.
Access Your Free Sample Report For In-Depth Market Analysis:
What Factors Are Contributing To The Growth Of The Artificial Intelligence In Life Sciences Market?
Growing demand for real-time remote patient monitoring (RPM) systems is anticipated to fuel the expansion of artificial intelligence within the life sciences market. These systems represent technology-enabled healthcare solutions designed to oversee patient well-being beyond conventional clinical environments. Artificial intelligence in life sciences plays a crucial role in remote patient monitoring by delivering ongoing, tailored, and data-informed insights, which facilitate proactive healthcare management. As an example, the Peterson Center on Healthcare, a US-based non-profit organization, reported in April 2025 that expenditures for remote therapeutic monitoring (RTM) in Traditional Medicare increased significantly from $2.2 million in 2022 to $10.4 million in 2023. Furthermore, in 2023, 451,000 patients in Traditional Medicare utilized RPM services. Consequently, the heightened interest in real-time remote patient monitoring (RPM) systems is stimulating the expansion of artificial intelligence in the life sciences market.
What Are The Different Segment Types In The Artificial Intelligence In Life Sciences Market Segment Breakdown?
The artificial intelligence in life sciences market covered in this report is segmented –
1) By Offering: Software, Hardware, Services
2) By Deployment: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring
Subsegments:
1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies
3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services
What Trends Are Shaping The Future Of The Artificial Intelligence In Life Sciences Market?
Leading companies in the artificial intelligence within the life sciences market are prioritizing innovative offerings, such as drug discovery software, enhanced by technological advancements, to maintain their market presence. This software category comprises computer programs and applications developed to assist pharmaceutical and biotechnology researchers in the new drug discovery process. For example, in December 2023, Merck, a Germany-based science and technology firm, launched AIDDISON, an innovative drug discovery software. As a unique solution, it links virtual molecule design with real-world production viability, employing generative AI, machine learning, and computer-aided drug design. AIDDISON effectively identifies prospective drug candidates from numerous possibilities, evaluating key attributes like non-toxicity and solubility. Its capacity to connect virtual molecule design with practical manufacturability stands out as a significant application of artificial intelligence in the life sciences domain.
Who Are The Well-Known Companies In The Artificial Intelligence In Life Sciences Market?
Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.
Get The Full Artificial Intelligence In Life Sciences Market Report:
Which Region Accounts For The Largest Portion Of The Artificial Intelligence In Life Sciences Market?
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence In Life Sciences Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Intelligence In Life Sciences Market 2026, By The Business Research Company
Life Science Analytics Market Report 2026
https://www.thebusinessresearchcompany.com/report/life-science-analytics-global-market-report
Ai In Life Science Analytics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report
Artificial Intelligence In Medicine Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model